Crossmark

Cancer recurrence risk with bDMARD treatment in patients with rheumatoid arthritis and a history of cancer: a nationwide Danish register-based cohort study

Crossref DOI link: https://doi.org/10.1136/rmdopen-2024-005247

Published Online: 2025-04-20

Published Print: 2025-04

Update policy: https://doi.org/10.1136/crossmarkpolicy

Authors

Westermann, Rasmus https://orcid.org/0000-0002-8148-9658
Cordtz, René

Duch, Kirsten

Mellemkjaer, Lene

Hetland, Merete Lund https://orcid.org/0000-0003-4229-6818
Rasmussen, Linda Aagaard

Dreyer, Lene
Funding

Funding for this research was provided by:

Danish Rheumatism Association

Danish Cancer Society
License Information

License valid from 2025-04-19

Document is current

Any future updates will be listed below